MTOR and hepatocellular carcinoma: Additionally, oncogenic pathways including PI3K/AKT/mTOR and Wnt/B-catenin are frequently dysregulated in HCC, through mutations in TERN, CTNNB1, and TP53, contributing to tumorigenesis and resistance to treatment [7,8,9].